Bhat Bhavana Brahmananda, Udupa Nayanabhirama, Sreedhar Dharmagadda
Department of Pharmacy Management, Manipal College of Pharmaceutical Sciences, MAHE, Manipal, Karnataka, India.
Directorate of Research, MAHE, Manipal, India.
Curr Drug Discov Technol. 2019;16(4):368-371. doi: 10.2174/1570163815666181105091254.
Herbal medicines have been used by mankind from time immemorial. Moreover, many modern medicines are originated from plant sources. In earlier days, patients were dependent on herbs for treatment and well-being. However, due to the advent of the industrial revolution and modern science, the scenario of treating diseases has changed over a period of time. Majority of patients started preferring allopathy medicines due to their several advantages over herbal medicines. However, due to long term treatment by allopathic medicines for chronic diseases led to side effects, patients are now drifting back to the traditional medicines. Herbal medicines have their own drawbacks, viz., lack of safety and efficacy data, standardization difficulties, not well established legislative controls and a few issues with adverse drug reactions. Drug regulations per se were always the prime focus and they are said to be dynamic. There are a few differences in regulations of herbal drugs among various countries. Regulatory authorities of countries are working to evolve the regulations to govern herbal medicines more effectively. A brief overview of the regulations related to a few developing and developed countries have been dealt here.
草药自古以来就被人类使用。此外,许多现代药物都源自植物。在早期,患者依靠草药进行治疗和维持健康。然而,由于工业革命和现代科学的出现,疾病治疗的情况在一段时间内发生了变化。由于与草药相比具有若干优势,大多数患者开始更喜欢使用对抗疗法药物。然而,由于使用对抗疗法药物长期治疗慢性病会产生副作用,患者现在又开始转向传统药物。草药有其自身的缺点,即缺乏安全性和有效性数据、标准化困难、立法控制不完善以及药物不良反应方面的一些问题。药品监管本身一直是首要关注点,而且据说它是动态的。各国在草药监管方面存在一些差异。各国监管机构正在努力完善法规,以更有效地管理草药。这里简要概述了一些发展中国家和发达国家与草药相关的法规。